dabigatran has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M; Leung, LLK; Leung, TH; Mizuno, S; Morser, J; Myles, T; Nishimura, T; Peraramelli, S; Stulnig, TM; Wanko, B; Zhao, L; Zhou, Q | 1 |
1 other study(ies) available for dabigatran and B16 Melanoma
| Article | Year |
|---|---|
Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.
Topics: Animals; Cell Adhesion; Dabigatran; Humans; Melanoma, Experimental; Mice; Osteopontin; Thrombin | 2022 |